- Filed
- Sep 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Sep 12, 2025 | 13.79M sh |
| Shares Diluted | Q1 2026 · Jul 31, 2025 | 13.79M sh |
| Shares Diluted | Q1 2026 · Jul 31, 2024 | 14.04M sh |
| Capex | Q1 2026 · Jul 31, 2025 | $46K |
| Capex | Q1 2026 · Jul 31, 2024 | $0 |
| Operating Cash Flow | Q1 2026 · Jul 31, 2025 | $600K |
| Operating Cash Flow | Q1 2026 · Jul 31, 2024 | $311K |
| Cash And Equivalents | Q1 2026 · Jul 31, 2025 | $10.33M |
| Cash And Equivalents | Q1 2026 · Apr 30, 2025 | $9.79M |
| Stockholders Equity | Q1 2026 · Jul 31, 2025 | $3.51M |
| Stockholders Equity | Q1 2026 · Apr 30, 2025 | $3.77M |
| Current Liabilities | Q1 2026 · Jul 31, 2025 | $22.7M |
| Current Liabilities | Q1 2026 · Apr 30, 2025 | $23.85M |
| Total Liabilities | Q1 2026 · Jul 31, 2025 | $27.01M |
| Total Liabilities | Q1 2026 · Apr 30, 2025 | $28.57M |
| Current Assets | Q1 2026 · Jul 31, 2025 | $21.01M |
| Current Assets | Q1 2026 · Apr 30, 2025 | $22.36M |
| Total Assets | Q1 2026 · Jul 31, 2025 | $30.55M |
| Total Assets | Q1 2026 · Apr 30, 2025 | $32.34M |
| Eps Diluted | Q1 2026 · Jul 31, 2025 | −$0.03 |
| Eps Diluted | Q1 2026 · Jul 31, 2024 | $0.09 |
| Eps Basic | Q1 2026 · Jul 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Jul 31, 2024 | $0.10 |
| Sga Expense | Q1 2026 · Jul 31, 2025 | $2.57M |
| Sga Expense | Q1 2026 · Jul 31, 2024 | $2.53M |
| Rd Expense | Q1 2026 · Jul 31, 2025 | $2.08M |
| Rd Expense | Q1 2026 · Jul 31, 2024 | $1.45M |
| Net Income | Q1 2026 · Jul 31, 2025 | −$436K |
| Net Income | Q1 2026 · Jul 31, 2024 | $1.31M |
| Operating Income | Q1 2026 · Jul 31, 2025 | −$527K |
| Operating Income | Q1 2026 · Jul 31, 2024 | $1.33M |
| Cost Of Revenue | Q1 2026 · Jul 31, 2025 | $8M |
| Cost Of Revenue | Q1 2026 · Jul 31, 2024 | $7.07M |
| Revenue | Q1 2026 · Jul 31, 2025 | $14M |
| Revenue | Q1 2026 · Jul 31, 2024 | $14.06M |